Similar articles

• Evolving Pharmacologic Therapies for Heart Failure.

  Clem JR, Heins J. Clem JR, et al. S D Med. 2017 Apr;70(4):180-181. S D Med. 2017. PMID: 28813736 No abstract available.
• [Update on the clinical application of valsartan/sacubitril in patients with heart failure].

  [No authors listed] [No authors listed] Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jun 24;45(6):538-541. doi: 10.3760/cma.j.issn.0253-3758.2017.06.018. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 28648033 Chinese. No abstract available.
• Sacubitril/Valsartan: Practice Changing Guideline in the Management of Congestive Heart Failure.

  Karim MA, Siddiqui HU, Ullah S, Khan NAJ. Karim MA, et al. J Coll Physicians Surg Pak. 2017 Nov;27(11):733. J Coll Physicians Surg Pak. 2017. PMID: 29132491 No abstract available.
• Recent major advances in cardiovascular pharmacotherapy.

  Milner J, Cunha A, Gamboa-Cruz C, Reis J, Campos M, António N. Milner J, et al. Eur J Clin Pharmacol. 2018 Jul;74(7):853-862. doi: 10.1007/s00228-018-2453-1. Epub 2018 Mar 27. Eur J Clin Pharmacol. 2018. PMID: 29589064 Review.
• Potential Uses of Sacubitril/Valsartan: Need for Data on Efficacy and Safety.

  Huet F, Akodad M, Kalmanovitch E, Adda J, Agullo A, Batistella P, Roubille C, Roubille F. Huet F, et al. Am J Cardiovasc Drugs. 2019 Feb;19(1):1-10. doi: 10.1007/s40256-018-0306-z. Am J Cardiovasc Drugs. 2019. PMID: 30345485 Review.